American Association for Cancer Research Inaugurates 2014 Class of Fellows

Get Permission

The American Association for Cancer Research (AACR) inducted the 2014 class of elected Fellows of the AACR Academy at the Association’s Annual Meeting, held recently in San Diego. The AACR Academy is an entity within the AACR that recognizes those individuals who have made exceptional contributions to cancer research and/or cancer-related biomedical science.

“Our 2014 class of fellows includes a number of the most prestigious laboratory researchers and physician-scientists who have contributed enormously to the cancer field,” said Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR.

2014 Class of Fellows of the AACR Academy

Jerry Adams, PhD, Joint Head of the Molecular Genetics of Cancer Division and Director of the Leukemia and Lymphoma Society Specialized Center of Research, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

James P. Allison, PhD, Professor and Chair of the Department of Immunology, Director of the Immunology Platform, and Deputy Director of the David H. Koch Center for Applied Research in Genitourinary Cancers, Department of Genitourinary Research, The University of Texas MD Anderson Cancer Center, Houston, Texas

Mariano Barbacid, PhD, Professor of Molecular Oncology, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain

José Baselga, MD, PhD, Physician-in-Chief, Memorial Sloan Kettering Cancer Center, New York, N.Y.

Stephen B. Baylin, MD, Deputy Director and Associate Director for Research, Sidney Kimmel Comprehensive Cancer Center; Virginia and D.K. Ludwig Professor for Cancer Research and Medicine and Chief of the Cancer Biology Division, Johns Hopkins University School of Medicine, Baltimore.

Günter Blobel, MD, PhD, John D. Rockefeller Jr. Professor, Laboratory of Cell Biology, The Rockefeller University, New York; Investigator, Howard Hughes Medical Institute

David Botstein, PhD, Anthony B. Evnin Professor of Genomics, Princeton University, Princeton; Chief Scientific Officer, Calico, San Francisco

Joan S. Brugge, PhD, Louise Foote Pfeiffer professor of cell biology and chair of the Department of Cell Biology, Harvard Medical School, Boston

Lewis C. Cantley, PhD, Margaret and Herman Sokol Professor and Director of the Meyer Cancer Center, Weill Cornell Medical College, affiliated with New York-Presbyterian Hospital, New York

Pierre Chambon, MD, Honorary Professor, Collège-de-France; Professor of Molecular Biology and Genetics, Institute for Advanced Study, University of Strasbourg; Group Leader, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch-Graffenstaden, Strasburg, France

Hans Clevers, MD, PhD, Professor in Medical Genetics, University of Utrecht; President of the Royal Netherlands Academy of Arts and Sciences, Hubrecht Institute, Utrecht, Netherlands

James E. Darnell Jr., MD, Vincent Astor Professor Emeritus and Head, Laboratory of Molecular Cell Biology, The Rockefeller University, New York

Titia de Lange, PhD, Leon Hess Professor, American Cancer Society Research Professor, and Director of the Anderson Center for Cancer Research, The Rockefeller University, New York

Vincent T. DeVita Jr., MD, Amy and Joseph Perella Professor of Medicine, Yale Cancer Center; Pprofessor of Epidemiology and Public Health, Yale Medical School, New Haven

Lawrence H. Einhorn, MD, Distinguished Professor of Medicine and Lance Armstrong Foundation Professor of Medicine, Indiana University School of Medicine, Indianapolis

Stephen J. Elledge, PhD, Gregor Mendel Professor of Genetics and Medicine, Department of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women’s Hospital, Boston

Ronald M. Evans, PhD, Professor and Director of the Gene Expression Laboratory and March of Dimes Chair in Molecular and Developmental Biology, The Salk Institute for Biological Studies, La Jolla; Investigator, Howard Hughes Medical Institute

Andrew Z. Fire, PhD, Departments of Pathology and Genetics, George D. Smith Professor in Molecular and Genetic Medicine, Stanford University School of Medicine

Emil J. Freireich, MD, Ruth Harriet Ainsworth Chair, Distinguished Teaching Professor, Director of the Adult Leukemia Research Program, and Director of the Special Medical Education Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas

Robert C. Gallo, MD, Homer and Martha Gudelsky Distinguished Professor of Medicine, Professor of Medicine and of Microbiology and Immunology, and Director of the Institute of Human Virology, University of Maryland School of Medicine, College Park, Maryland

Douglas Hanahan, PhD, Director of the Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Department of Life Sciences, Lausanne, Switzerland

Richard O. Hynes, PhD, Daniel K. Ludwig Professor for Cancer Research, Massachusetts Institute of Technology; Investigator, Howard Hughes Medical Institute

William G. Kaelin Jr., MD, Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston; Investigator, Howard Hughes Medical Institute

Kenneth W. Kinzler, PhD, Professor of Oncology and Director of the Ludwig Center, Johns Hopkins University, Johns Hopkins Kimmel Cancer Center, Baltimore

Richard D. Kolodner, PhD, Member and Head of the Laboratory of Cancer Genetics, Ludwig Institute for Cancer Research; Distinguished Professor in the Departments of Medicine and Cellular and Molecular Medicine, University of California, San Diego School of Medicine, San Diego

Ronald Levy, MD, Robert K. and Helen K. Summy Professor of Medicine, Stanford University School of Medicine, Palo Alto

Frederick P. Li, MD, Professor of Clinical Cancer Epidemiology Emeritus, Harvard School of Public Health; Professor of Medicine Emeritus, Dana-Farber Cancer Institute, Boston

David M. Livingston, MD, Deputy Director of the Dana-Farber Cancer Institute, Chief of the Charles A. Dana Division of Human Cancer Genetics, and Emil Frei Professor of Genetics and Medicine, Harvard Medical School, Boston

Paul A. Marks, MD, President Emeritus, Memorial Sloan Kettering Cancer Center, New York

Peter C. Nowell, MD, Gaylord P. and Mary Louise Harnwell Professor Emeritus in the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia

Christiane Nüsslein-Volhard, PhD, Director of the Department of Genetics, Max Planck Institute for Developmental Biology, Tübingen, Germany

Sir Richard Peto, FRS, Professor of Medical Statistics and Epidemiology, University of Oxford, Oxford, United Kingdom

Charles L. Sawyers, MD, Chairperson of the Human Oncology and Pathogenesis Program and member at Memorial Sloan Kettering Cancer Center; Professor, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York; Investigator, Howard Hughes Medical Institute

Sir Michael R. Stratton, MBBS, PhD, Director, Wellcome Trust Sanger Institute, Cambridge, United Kingdom

Axel Ullrich, PhD, Director of the Department of Molecular Biology, Max Planck Institute of Biochemistry, Munich, Germany

Inder M. Verma, PhD, Irwin and Joan Jacobs Chair in Exemplary Life Science and American Cancer Society Professor of Molecular Biology, The Salk Institute for Biological Sciences, La Jolla

Irving L. Weissman, MD, Director of the Institute for Stem Cell Biology and Regenerative Medicine, Director of the Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, and Professor of Pathology and Developmental Biology, Stanford University School of Medicine, Palo Alto

Owen N. Witte, MD, Director of the Broad Stem Cell Research Center and Distinguished Professor of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles; Investigator at Howard Hughes Medical Institute ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.